Aduro BioTech's Corporate Minority Round

Aduro BioTech raised a round of funding on March 30, 2015. Investors include Novartis.

Aduro is advancing multiple therapeutic and prophylactic vaccines for cancer and infectious diseases based on its attenuated Listeria monocytogenes vaccine platforms. The company is also advancing a n…

Articles about Aduro BioTech's Corporate Minority Round: